Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

Human Molecular Genetics

Volumn 24, Issue 10, 2015, Pages 2966-2984

  Orr, Nick ^a   Dudbridge, Frank ^b   Dryden, Nicola ^a   Maguire, Sarah ^a   Novo, Daniela ^a   Perrakis, Eleni ^a   Johnson, Nichola ^a   Ghoussaini, Maya ^c   Hopper, John L ^d   Southey, Melissa C ^e   Apicella, Carmel ^d   Stone, Jennifer ^f   Schmidt, Marjanka K ^g   Broeks, Annegien ^g   Van't Veer, Laura J ^g   Hogervorst, Frans B ^g   Fasching, Peter A ^h,i   Haeberle, Lothar ^h   Ekici, Arif B ^h   Beckmann, Matthias W ^h   Gibson, Lorna ^b   Aitken, Zoe ^b   Warren, Helen ^j,k   Sawyer, Elinor ^l   Tomlinson, Ian ^m   Kerin, Michael J ⁿ   Miller, Nicola ⁿ   Burwinkel, Barbara ^o,p   Marme, Frederik ^o   Schneeweiss, Andreas ^o   Sohn, Chistof ^o   Guénel, Pascal ^q,r   Truong, Thérèse ^q,r   Cordina Duverger, Emilie ^q,r   Sanchez, Marie ^q,r   Bojesen, Stig E ^s   Nordestgaard, Børge G ^s   Nielsen, Sune F ^s   Flyger, Henrik ^s   Benitez, Javier ^t,u   Zamora, Maria Pilar ^v   Perez, Jose Ignacio Arias ^w   Menéndez, Primitiva ^w   Anton Culver, Hoda ^x   Neuhausen, Susan L ^y   Brenner, Hermann ^p   Dieffenbach, Aida Karina ^p   Arndt, Volker ^p   Stegmaier, Christa ^z   Hamann, Ute ^p   Brauch, Hiltrud ^p,aa,ab   Justenhoven, Christina ^aa,ab   Brüning, Thomas ^ac   Ko, Yon Dschun ^ad   Nevanlinna, Heli ^ae   Aittomäki, Kristiina ^ae   Blomqvist, Carl ^ae   Khan, Sofia ^ae   Bogdanova, Natalia ^af   Dörk, Thilo ^af   Lindblom, Annika ^ag   Margolin, Sara ^ag   Mannermaa, Arto ^ah,ai   Kataja, Vesa ^ah,ai,aj   Kosma, Veli Matti ^ah,ai   Hartikainen, Jaana M ^ah,ai   Chenevix Trench, Georgia ^ak   Beesley, Jonathan ^ak   Lambrechts, Diether ^al,am   Moisse, Matthieu ^al,am   Floris, Guiseppe ^an   Beuselinck, Benoit ^an   Chang Claude, Jenny ^p   Rudolph, Anja ^p   Seibold, Petra ^p   Flesch Janys, Dieter ^ao   Radice, Paolo ^ap   Peterlongo, Paolo ^aq   Peissel, Bernard ^ap   Pensotti, Valeria ^aq,ar   Couch, Fergus J ^as   Olson, Janet E ^as   Slettedahl, Seth ^as   Vachon, Celine ^as   Giles, Graham G ^d,at   Milne, Roger L ^d,at   McLean, Catriona ^au   Haiman, Christopher A ^av   Henderson, Brian E ^av   Schumacher, Fredrick ^av   Le Marchand, Loic ^aw   Simard, Jacques ^ax   Goldberg, Mark S ^ay,az   Labrèche, France ^ba   Dumont, Martine ^ax   Kristensen, Vessela ^bb,bc   Alnæs, Grethe Grenaker ^ba   Nord, Silje ^bb   Borresen Dale, Anne Lise ^bb,bc   Zheng, Wei ^bd   Deming Halverson, Sandra ^bd   Shrubsole, Martha ^bd   Long, Jirong ^bd   Winqvist, Robert ^be   Pylkäs, Katri ^be   Jukkola Vuorinen, Arja ^be   Grip, Mervi ^bf   Andrulis, Irene L ^bg,bh   Knight, Julia A ^bg,bi   Glendon, Gord ^bg   Tchatchou, Sandrine ^bg   Devilee, Peter ^bj   Tollenaar, Robertus A E M ^bj   Seynaeve, Caroline M ^bk   Van Asperen, Christi J ^bj   Garcia Closas, Montserrat ^a   Figueroa, Jonine ^bl   Chanock, Stephen J ^bl   Lissowska, Jolanta ^bm   Czene, Kamila ^ag   Darabi, Hatef ^ag   Eriksson, Mikael ^ag   Klevebring, Daniel ^bm   Hooning, Maartje J ^bk   Hollestelle, Antoinette ^bk   Van Deurzen, Carolien H M ^bn   Kriege, Mieke ^bk   Hall, Per ^ag   Li, Jingmei ^bo   Liu, Jianjun ^bo   Humphreys, Keith ^ag   Cox, Angela ^bp   Cross, Simon S ^bp   Reed, Malcolm W R ^bq   Pharoah, Paul D P ^c   Dunning, Alison M ^c   Shah, Mitul ^c   Perkins, Barbara J ^c   Jakubowska, Anna ^br   Lubinski, Jan ^br   Jaworska Bieniek, Katarzyna ^br   Durda, Katarzyna ^br   Ashworth, Alan ^a   Swerdlow, Anthony ^a   Jones, Michael ^a   Schoemaker, Minouk J ^a   Meindl, Alfons ^bs   Schmutzler, Rita K ^bt   Olswold, Curtis ^as   Slager, Susan ^as   Toland, Amanda E ^bu   Yannoukakos, Drakoulis ^bv   Muir, Kenneth ^bw,bx   Lophatananon, Artitaya ^bw   Stewart Brown, Sarah ^bw   Siriwanarangsan, Pornthep ^by   Matsuo, Keitaro ^bz   Ito, Hidema ^ca   Iwata, Hiroji ^ca   Ishiguro, Junko ^ca   Wu, Anna H ^av   Tseng, Chiu chen ^av   Van Den Berg, David ^av   Stram, Daniel O ^av   Teo, Soo Hwang ^cb,cc   Yip, Cheng Har ^cc   Kang, Peter ^cb   Ikram, Mohammad Kamran ^cd   Shu, Xiao Ou ^bd   Lu, Wei ^ce   Gao, Yu Tang ^cf   Cai, Hui ^bd   Kang, Daehee ^cg,ch   Choi, Ji Yeob ^ch   Park, Sue K ^cg,ch   Noh, Dong Young ^cg   Hartman, Mikael ^cd,ci,cj   Miao, Hui ^cd,cj   Lim, Wei Yen ^cd,cj   Lee, Soo Chin ^cj,ck   Sangrajrang, Suleeporn ^cl   Gaborieau, Valerie ^cm   Brennan, Paul ^cm   Mckay, James ^cm   Wu, Pei Ei ^cn,co   Hou, Ming Feng ^cp   Yu, Jyh Cherng ^cq   Shen, Chen Yang ^cp,cr   Blot, William ^bd,cs   Cai, Qiuyin ^bd   Signorello, Lisa B ^ct,cu   Luccarini, Craig ^c   Bayes, Caroline ^c   Ahmed, Shahana ^c   Maranian, Mel ^c   Healey, Catherine S ^c   González Neira, Anna ^t   Pita, Guillermo ^t   Rosario Alonso, M ^t   Álvarez, Nuria ^t   Herrero, Daniel ^t   Tessier, Daniel C ^ay   Vincent, Daniel ^ay   Bacot, Francois ^ay   Hunter, David J ^cu   Lindstrom, Sara ^cu   Dennis, Joe ^c   Michailidou, Kyriaki ^c   Bolla, Manjeet K ^c   Easton, Douglas F ^c   Dos Santos Silva, Isabel ^b   Fletcher, Olivia ^a   Peto, Julian ^b   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^k QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^l GUY S HOSPITAL   (United Kingdom)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ UNIVERSITY HOSPITAL GALWAY   (Ireland)

^o UNIVERSITY OF HEIDELBERG   (Germany)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q NATIONAL INSTITUTES OF HEALTH   (United States)

^r UNIVERSITÉ PARIS SACLAY   (France)

^s GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^t Centro Nacional de Investigaciones Oncológicas   (Spain)

^u CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^v HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^w HOSPITAL MONTE NARANCO   (Spain)

^x UNIVERSITY OF CALIFORNIA   (United States)

^y CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^z SAARLAND CANCER REGISTRY   (Germany)

^aa DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^ab UNIVERSITY OF TÜBINGEN   (Germany)

^ac RUHR UNIVERSITY BOCHUM   (Germany)

^ad Johanniter Krankenhaus   (Germany)

^ae UNIVERSITY OF HELSINKI   (Finland)

^af HANNOVER MEDICAL SCHOOL   (Germany)

^ag KAROLINSKA INSTITUTE   (Sweden)

^ah UNIVERSITY OF EASTERN FINLAND   (Finland)

^ai KUOPIO UNIVERSITY HOSPITAL   (Finland)

^aj JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^ak QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^al Vesalius Research Center (VRC)   (Belgium)

^am UNIVERSITY OF LEUVEN   (Belgium)

^an UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^ao UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^ap NATIONAL CANCER INSTITUTE   (Italy)

^aq FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^ar Cogentech Cancer Genetic Test Laboratory ^*  (Italy)

^as MAYO CLINIC   (United States)

^at CANCER EPIDEMIOLOGY CENTRE   (Australia)

^au ALFRED HOSPITAL   (Australia)

^av UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^aw UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^ax Université Laval   (Canada)

^ay MCGILL UNIVERSITY   (Canada)

^az ROYAL VICTORIA HOSPITAL   (Canada)

^ba UNIVERSITÉ DE MONTRÉAL   (Canada)

^bb OSLO UNIVERSITY HOSPITAL   (Norway)

^bc UNIVERSITY OF OSLO   (Norway)

^bd VANDERBILT INGRAM CANCER CENTER   (United States)

^be UNIVERSITY OF OULU   (Finland)

^bf OULU UNIVERSITY HOSPITAL   (Finland)

^bg MOUNT SINAI HOSPITAL   (Canada)

^bh UNIVERSITY OF TORONTO   (Canada)

^bi UNIVERSITY OF TORONTO   (Canada)

^bj LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bk ERASMUS MC CANCER INSTITUTE   (Netherlands)

^bl NATIONAL CANCER INSTITUTE   (United States)

^bm INSTITUTE OF ONCOLOGY   (Poland)

^bn ERASMUS MEDICAL CENTER   (Netherlands)

^bo GENOME INSTITUTE OF SINGAPORE   (Singapore)

^bp UNIVERSITY OF SHEFFIELD   (United Kingdom)

^bq UNIVERSITY OF SUSSEX   (United Kingdom)

^br POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bs TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^bt UNIVERSITY OF COLOGNE   (Germany)

^bu OHIO STATE UNIVERSITY   (United States)

^bv INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^bw UNIVERSITY OF WARWICK   (United Kingdom)

^bx UNIVERSITY OF MANCHESTER   (United Kingdom)

^by MINISTRY OF PUBLIC HEALTH   (Thailand)

^bz KYUSHU UNIVERSITY   (Japan)

^ca AICHI CANCER CENTER HOSPITAL   (Japan)

^cb CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^cc UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^cd NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^ce Shanghai Center for Disease Control and Prevention   (China)

^cf SHANGHAI CANCER INSTITUTE   (China)

^cg Seoul National University College of Medicine   (South Korea)

^ch Seoul National University   (South Korea)

^ci NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^cj NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^ck NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^cl NATIONAL CANCER INSTITUTE   (Thailand)

^cm INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^cn ACADEMIA SINICA   (Taiwan)

^co INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^cp KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^cq TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^cr CHINA MEDICAL UNIVERSITY   (Taiwan)

^cs INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^ct DANA FARBER HARVARD CANCER CENTER   (United States)

^cu HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HISTONE H3; KRUPPEL LIKE FACTOR 4; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR GATA 3; ESTROGEN RECEPTOR ALPHA, HUMAN; FOXA1 PROTEIN, HUMAN; GATA3 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR;

ADULT; AFRICAN; ALLELE; ARTICLE; ASIAN; BREAST CANCER; BREAST CANCER CELL LINE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CHROMATIN; CHROMOSOME 9Q; CONTROLLED STUDY; ENHANCER REGION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; EUROPEAN; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INDEL MUTATION; MAJOR CLINICAL STUDY; MCF 7 CELL LINE; PRIORITY JOURNAL; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; CHROMOSOMAL MAPPING; CHROMOSOME 9; CLINICAL TRIAL; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MULTICENTER STUDY; RISK;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; ENHANCER ELEMENTS, GENETIC; ESTROGEN RECEPTOR ALPHA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84929498060     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv035     Document Type: Article

References (47)

1. Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Pharoah, P.D., Antoniou, A., Bobrow, M., Zimmern, R.L., Easton, D.F. and Ponder, B.A. (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet., 31, 33-36.
3. Meijers-Heijboer, H., van den Ouweland, A., Klijn, J., Wasielewski, M., de Snoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., van Veghel-Plandsoen, M. et al. (2002) Lowpenetrance susceptibility to breast cancer due to CHEK2(*) 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31, 55-59.
4. Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T. et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet., 39, 165-167.
5. Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., Spanova, K. et al. (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet., 38, 873-875.
6. Easton, D.F., Pooley, K.A., Dunning, A.M., Pharoah, P.D., Thompson, D., Ballinger, D.G., Struewing, J.P., Morrison, J., Field, H., Luben, R. et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-1093.
7. Fletcher, O., Johnson, N., Orr, N., Hosking, F.J., Gibson, L.J., Walker, K., Zelenika, D., Gut, I., Heath, S., Palles, C. et al. (2011) Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J. Natl. Cancer Inst., 103, 425-435.
8. Ghoussaini, M., Fletcher, O., Michailidou, K., Turnbull, C., Schmidt, M.K., Dicks, E., Dennis, J., Wang, Q., Humphreys, M.K., Luccarini, C. et al. (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat. Genet., 44, 312-318.
9. Michailidou, K., Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J.,Milne, R.L., Schmidt,M.K., Chang-Claude, J., Bojesen, S.E., Bolla,M.K. et al. (2013) Large-scale genotyping identifies 41 newloci associatedwith breast cancer risk. Nat. Genet., 45, 353-361.
10. Stacey, S.N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S.A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A. et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet., 39, 865-869.
11. Stacey, S.N., Manolescu, A., Sulem, P., Thorlacius, S., Gudjonsson, S.A., Jonsson, G.F., Jakobsdottir, M., Bergthorsson, J. T., Gudmundsson, J., Aben, K.K. et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor- positive breast cancer. Nat. Genet., 40, 703-706.
12. Thomas, G., Jacobs, K.B., Kraft, P., Yeager, M., Wacholder, S., Cox, D.G., Hankinson, S.E., Hutchinson, A., Wang, Z., Yu, K. et al. (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet., 41, 579-584.
13. Turnbull, C., Ahmed, S., Morrison, J., Pernet, D., Renwick, A., Maranian, M., Seal, S., Ghoussaini, M., Hines, S., Healey, C.S. et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet., 42, 504-507.
14. Zheng, W., Long, J., Gao, Y.T., Li, C., Zheng, Y., Xiang, Y.B., Wen, W., Levy, S., Deming, S.L., Haines, J.L. et al. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet., 41, 324-328.
15. Bojesen, S.E., Pooley, K.A., Johnatty, S.E., Beesley, J., Michailidou, K., Tyrer, J.P., Edwards, S.L., Pickett, H.A., Shen, H.C., Smart, C.E. et al. (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet., 45, 371-384.
16. French, J.D., Ghoussaini, M., Edwards, S.L., Meyer, K.B., Michailidou, K., Ahmed, S., Khan, S., Maranian, M.J., O'Reilly, M., Hillman, K.M. et al. (2013) Functional variants at the 11q13 Risk Locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am. J. Hum. Genet., 92, 489-503.
17. Garcia-Closas, M., Couch, F.J., Lindstrom, S., Michailidou, K., Schmidt, M.K., Brook, M.N., Orr, N., Rhie, S.K., Riboli, E., Feigelson, H.S. et al. (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet., 45, 392-398.
18. Meyer, K.B., O'Reilly, M., Michailidou, K., Carlebur, S., Edwards, S.L., French, J.D., Prathalingham, R., Dennis, J., Bolla, M.K., Wang, Q. et al. (2013) Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am. J. Hum. Genet., 93, 1046-1060.
19. Sawyer, E., Roylance, R., Petridis, C., Brook, M.N., Nowinski, S., Papouli, E., Fletcher, O., Pinder, S., Hanby, A., Kohut, K. et al. (2014) Genetic predisposition to in situ and invasive lobular carcinoma of the breast. PLoS Genet., 10, e1004285.
20. Burton, H., Chowdhury, S., Dent, T., Hall, A., Pashayan, N. and Pharoah, P. (2013) Public health implications from COGS and potential for risk stratification and screening. Nat. Genet., 45, 349-351.
21. Warren, H., Dudbridge, F., Fletcher, O., Orr, N., Johnson, N., Hopper, J.L., Apicella, C., Southey, M.C., Mahmoodi, M., Schmidt, M.K. et al. (2012) 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence fromthe Breast Cancer Association Consortium. Cancer Epidemiol. Biomarkers Prev., 21, 1783-1791.
22. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
23. Edwards, S.L., Beesley, J., French, J.D. and Dunning, A.M. (2013) BeyondGWASs: illuminating the dark road fromassociation to function. Am. J. Hum. Genet., 93, 779-797.
24. Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C. and Snyder, M. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
25. Frietze, S.,Wang, R., Yao, L., Tak, Y.G., Ye, Z., Gaddis, M.,Witt, H., Farnham, P.J. and Jin, V.X. (2012) Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3. Genome Biol., 13, R52.
26. Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N.,Ward, L. D., Epstein, C.B., Zhang, X.,Wang, L., Issner, R., Coyne, M. et al. (2011) Mapping and analysis of chromatin state dynamics in nine human cell types. Nature, 473, 43-49.
27. Kittler, R., Zhou, J., Hua, S., Ma, L., Liu, Y., Pendleton, E., Cheng, C., Gerstein, M. and White, K.P. (2013) A comprehensive nuclear receptor network for breast cancer cells. Cell Rep., 3, 538-551.
28. Kouros-Mehr, H., Slorach, E.M., Sternlicht, M.D. and Werb, Z. (2006) GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell, 127, 1041-1055.
29. Sanders, D.A., Ross-Innes, C.S., Beraldi, D., Carroll, J.S. and Balasubramanian, S. (2013) Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells. Genome Biol., 14, R6.
30. Boyle, A.P., Hong, E.L., Hariharan, M., Cheng, Y., Schaub, M.A., Kasowski, M., Karczewski, K.J., Park, J., Hitz, B.C., Weng, S. et al. (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res., 22, 1790-1797.
31. Hurtado, A., Holmes, K.A., Ross-Innes, C.S., Schmidt, D. and Carroll, J.S. (2011) FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet., 43, 27-33.
32. Li, Q., Seo, J.H., Stranger, B.,McKenna, A., Pe'er, I., Laframboise, T., Brown, M., Tyekucheva, S. and Freedman, M.L. (2013) Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell, 152, 633-641.
33. Mavaddat, N., Antoniou, A.C., Easton, D.F. and Garcia-Closas, M. (2010) Genetic susceptibility to breast cancer. Mol. Oncol., 4, 174-191.
34. Haiman, C.A., Chen, G.K., Vachon, C.M., Canzian, F., Dunning, A., Millikan, R.C., Wang, X., Ademuyiwa, F., Ahmed, S., Ambrosone, C.B. et al. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptornegative breast cancer. Nat. Genet., 43, 1210-1214.
35. Siddiq, A., Couch, F.J., Chen, G.K., Lindstrom, S., Eccles, D., Millikan, R.C., Michailidou, K., Stram, D.O., Beckmann, L., Rhie, S.K. et al. (2012) A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum. Mol. Genet., 21, 5373-5384.
36. NCI-NHGRIWorking Group on Replication in Association Studies Chanock, S.J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D.J., Thomas, G., Hirschhorn, J.N., Abecasis, G., Altshuler, D. et al. (2007) Replicating genotype-phenotype associations. Nature, 447, 655-660.
37. Carroll, J.S., Liu, X.S., Brodsky, A.S., Li, W., Meyer, C.A., Szary, A.J., Eeckhoute, J., Shao, W., Hestermann, E.V., Geistlinger, T. R. et al. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell, 122, 33-43.
38. Eeckhoute, J., Keeton, E.K., Lupien, M., Krum, S.A., Carroll, J.S. and Brown, M. (2007) Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res., 67, 6477-6483.
39. Theodorou, V., Stark, R., Menon, S. and Carroll, J.S. (2013) GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Res., 23, 12-22.
40. Cowper-Sal Lari, R., Zhang, X., Wright, J.B., Bailey, S.D., Cole, M.D., Eeckhoute, J., Moore, J.H. and Lupien, M. (2012) Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat. Genet., 44, 1191-1198.
41. Li, Q., Stram, A., Chen, C., Kar, S., Gayther, S., Pharoah, P., Haiman, C., Stranger, B., Kraft, P. and Freedman, M.L. (2014) Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types. Hum. Mol. Genet., 23, 5294-5302.
42. Rowland, B.D., Bernards, R. and Peeper,D.S. (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol., 7, 1074-1082.
43. Foster, K.W., Frost, A.R., McKie-Bell, P., Lin, C.Y., Engler, J.A., Grizzle, W.E. and Ruppert, J.M. (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res., 60, 6488-6495.
44. Ernst, J. and Kellis, M. (2010) Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol., 28, 817-825.
45. van Berkum, N.L., Lieberman-Aiden, E.,Williams, L., Imakaev, M., Gnirke, A., Mirny, L.A., Dekker, J. and Lander, E.S. (2010) Hi-C: a method to study the three-dimensional architecture of genomes. J. Vis. Exp., 39.
46. Miele, A., Gheldof, N., Tabuchi, T.M., Dostie, J. and Dekker, J. (2006) Mapping chromatin interactions by chromosome conformation capture. Curr. Protoc. Mol. Biol., Chapter 21, Unit 21.11.
47. Broeks, A., Schmidt, M.K., Sherman, M.E., Couch, F.J., Hopper, J.L., Dite, G.S., Apicella, C., Smith, L.D., Hammet, F., Southey, M.C. et al. (2011) Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum. Mol. Genet., 20, 3289-3303.